Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Feb;36(2):198–202. doi: 10.1136/gut.36.2.198

Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation.

P J Hu 1, Y Y Li 1, M H Zhou 1, M H Chen 1, G G Du 1, B J Huang 1, H M Mitchell 1, S L Hazell 1
PMCID: PMC1382404  PMID: 7883217

Abstract

This study examines the relationship between Helicobacter pylori infection and peptic ulcer disease and gastric cancer--in particular, the presence or absence of bacteria, the grading of gastritis, and the degree of inflammation in the antral and oxyntic mucosae. The grading of gastritis and the detection of H pylori were determined by histology using the Sydney system. Of the 1006 patients examined, 34.5% had duodenal ulcer disease, 3.5% gastric ulcer disease, and 2% with coexistent ulceration. Most patients (50.2%) were classified as having non-ulcer dyspepsia. Altogether 2.4% of patients had gastric cancer and two further patients had carcinoma in the gastric stump. Of the ulcer disease patients, 87.2% had histological evidence of H pylori infection. After patients who had taken antibiotics or bismuth compounds in the preceding four weeks were excluded, 98.9% of the duodenal ulcer disease, 100% of the gastric ulcer disease, and 100% of the coexistent ulcer disease patients had evidence of H pylori infection. In patients with gastric cancer who had not taken antimicrobial agents in the four weeks before endoscopy, 83.3% had evidence of H pylori infection. Thus, there was a high rate of duodenal ulcer disease and a low rate of gastric ulcer disease in southern China, an area of low gastric cancer mortality. There was a specific topographical relationship between H pylori, the histological response, and gastroduodenal disease. Our data suggest that the status of a nation as either 'developed' or 'developing' can not be used to predict the upper gastrointestinal disease profile of its population.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet. 1993 May 29;341(8857):1359–1362. [PubMed] [Google Scholar]
  2. Bell G. D., Powell K. U. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol Suppl. 1993;196:7–11. doi: 10.3109/00365529309098334. [DOI] [PubMed] [Google Scholar]
  3. Burstein M., Monge E., León-Barúa R., Lozano R., Berendson R., Gilman R. H., Legua H., Rodriguez C. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol. 1991 Apr;13(2):154–156. doi: 10.1097/00004836-199104000-00007. [DOI] [PubMed] [Google Scholar]
  4. Buruk F., Berberoglu U., Pak I., Aksaz E., Celen O. Gastric cancer and Helicobacter pylori infection. Br J Surg. 1993 Mar;80(3):378–379. doi: 10.1002/bjs.1800800339. [DOI] [PubMed] [Google Scholar]
  5. Coghlan J. G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet. 1987 Nov 14;2(8568):1109–1111. doi: 10.1016/s0140-6736(87)91545-5. [DOI] [PubMed] [Google Scholar]
  6. Correa P., Fox J., Fontham E., Ruiz B., Lin Y. P., Zavala D., Taylor N., Mackinley D., de Lima E., Portilla H. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer. 1990 Dec 15;66(12):2569–2574. doi: 10.1002/1097-0142(19901215)66:12<2569::aid-cncr2820661220>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24):6735–6740. [PubMed] [Google Scholar]
  8. Fich A., Talley N. J., Shorter R. G., Phillips S. F. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci. 1991 Jan;36(1):10–14. doi: 10.1007/BF01300079. [DOI] [PubMed] [Google Scholar]
  9. Forman D. Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst. 1991 Dec 4;83(23):1702–1703. doi: 10.1093/jnci/83.23.1702. [DOI] [PubMed] [Google Scholar]
  10. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991 Jun 1;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fox J. G., Correa P., Taylor N. S., Zavala D., Fontham E., Janney F., Rodriguez E., Hunter F., Diavolitsis S. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol. 1989 Jul;84(7):775–781. [PubMed] [Google Scholar]
  12. Graham D. Y., Lew G. M., Klein P. D., Evans D. G., Evans D. J., Jr, Saeed Z. A., Malaty H. M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 1;116(9):705–708. doi: 10.7326/0003-4819-116-9-705. [DOI] [PubMed] [Google Scholar]
  13. Graham D. Y., Smith J. L. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol. 1988 Oct;83(10):1081–1084. [PubMed] [Google Scholar]
  14. Graham D. Y. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med. 1993 Feb 4;328(5):349–350. doi: 10.1056/NEJM199302043280512. [DOI] [PubMed] [Google Scholar]
  15. Hazell S. L., Hennessy W. B., Borody T. J., Carrick J., Ralston M., Brady L., Lee A. Campylobacter pyloridis gastritis II: Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol. 1987 Apr;82(4):297–301. [PubMed] [Google Scholar]
  16. Hu P. J., Li Y. Y., Mitchell H. M., Zhou M. H., Chen M. H., Du G. G., Huang B. J., Lee A., Hazell S. L. Oxyntic and antral gastritis in the People's Republic of China: diagnosis and relationship to Helicobacter pylori. Am J Gastroenterol. 1992 Jun;87(6):741–745. [PubMed] [Google Scholar]
  17. Hui P. K., Chan W. Y., Cheung P. S., Chan J. K., Ng C. S. Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol. 1992 May;23(5):548–556. doi: 10.1016/0046-8177(92)90132-m. [DOI] [PubMed] [Google Scholar]
  18. Hui W. M., Lam S. K., Ho J., Lai C. L., Lok A. S., Ng M. M., Lau W. Y., Branicki F. J. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci. 1991 May;36(5):577–582. doi: 10.1007/BF01297022. [DOI] [PubMed] [Google Scholar]
  19. Jankowski J. Helicobacter pylori infection and gastric cancer. BMJ. 1991 Jun 22;302(6791):1534–1534. doi: 10.1136/bmj.302.6791.1534-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Klein P. D., Graham D. Y., Gaillour A., Opekun A. R., Smith E. O. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet. 1991 Jun 22;337(8756):1503–1506. doi: 10.1016/0140-6736(91)93196-g. [DOI] [PubMed] [Google Scholar]
  21. Kolt S. D., Kronborg I. J., Yeomans N. D. High prevalence of duodenal ulcer in Indochinese immigrants attending an Australian university hospital. J Gastroenterol Hepatol. 1993 Mar-Apr;8(2):128–132. doi: 10.1111/j.1440-1746.1993.tb01502.x. [DOI] [PubMed] [Google Scholar]
  22. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  23. Lam S. K. Peptic ulcer: from epidemiology to cause. J Gastroenterol Hepatol. 1989;4 (Suppl 2):1–6. [PubMed] [Google Scholar]
  24. Laurén P. A., Nevalainen T. J. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer. 1993 May 15;71(10):2926–2933. doi: 10.1002/1097-0142(19930515)71:10<2926::aid-cncr2820711007>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  25. Leung K. M., Hui P. K., Chan W. Y., Thomas T. M. Helicobacter pylori-related gastritis and gastric ulcer. A continuum of progressive epithelial degeneration. Am J Clin Pathol. 1992 Dec;98(6):569–574. doi: 10.1093/ajcp/98.6.569. [DOI] [PubMed] [Google Scholar]
  26. Li Y. Y., Hu P. J., Du G. G., Hazell S. L. The prevalence of Helicobacter pylori infection in the Peoples Republic of China. Am J Gastroenterol. 1991 Apr;86(4):446–449. [PubMed] [Google Scholar]
  27. Marshall B. J., Goodwin C. S., Warren J. R., Murray R., Blincow E. D., Blackbourn S. J., Phillips M., Waters T. E., Sanderson C. R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24;2(8626-8627):1437–1442. doi: 10.1016/s0140-6736(88)90929-4. [DOI] [PubMed] [Google Scholar]
  28. Mitchell H. M., Li Y. Y., Hu P. J., Liu Q., Chen M., Du G. G., Wang Z. J., Lee A., Hazell S. L. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis. 1992 Jul;166(1):149–153. doi: 10.1093/infdis/166.1.149. [DOI] [PubMed] [Google Scholar]
  29. Nanivadekar S. A., Sawant P. D., Patel H. D., Shroff C. P., Popat U. R., Bhatt P. P. Association of peptic ulcer with Helicobacter pylori and the recurrence rate. A three year follow-up study. J Assoc Physicians India. 1990 Sep;38 (Suppl 1):703–706. [PubMed] [Google Scholar]
  30. Nomura A., Stemmermann G. N. Helicobacter pylori and gastric cancer. J Gastroenterol Hepatol. 1993 May-Jun;8(3):294–303. doi: 10.1111/j.1440-1746.1993.tb01202.x. [DOI] [PubMed] [Google Scholar]
  31. Parsonnet J., Vandersteen D., Goates J., Sibley R. K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991 May 1;83(9):640–643. doi: 10.1093/jnci/83.9.640. [DOI] [PubMed] [Google Scholar]
  32. Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
  33. Rauws E. A. Campylobacter pylori as possible factor in peptic ulcer recurrence. Acta Gastroenterol Belg. 1989 May-Aug;52(3-4):320–323. [PubMed] [Google Scholar]
  34. Schubert T. T., Bologna S. D., Nensey Y., Schubert A. B., Mascha E. J., Ma C. K. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med. 1993 Apr;94(4):413–418. doi: 10.1016/0002-9343(93)90153-g. [DOI] [PubMed] [Google Scholar]
  35. Scott N., Lansdown M., Diament R., Rathbone B., Murday V., Wyatt J. I., McMahon M., Dixon M. F., Quirke P. Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet. 1990 Mar 24;335(8691):728–728. doi: 10.1016/0140-6736(90)90845-v. [DOI] [PubMed] [Google Scholar]
  36. Sipponen P., Kosunen T. U., Valle J., Riihelä M., Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 1992 Apr;45(4):319–323. doi: 10.1136/jcp.45.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sipponen P. Natural history of gastritis and its relationship to peptic ulcer disease. Digestion. 1992;51 (Suppl 1):70–75. doi: 10.1159/000200919. [DOI] [PubMed] [Google Scholar]
  38. Soll A. H., Weinstein W. M., Kurata J., McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med. 1991 Feb 15;114(4):307–319. doi: 10.7326/0003-4819-114-4-307. [DOI] [PubMed] [Google Scholar]
  39. Stolte M., Eidt S., Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol. 1990 May;28(5):229–233. [PubMed] [Google Scholar]
  40. Tatsuta M., Iishi H., Okuda S., Taniguchi H., Yokota Y. The association of Helicobacter pylori with differentiated-type early gastric cancer. Cancer. 1993 Sep 15;72(6):1841–1845. doi: 10.1002/1097-0142(19930915)72:6<1841::aid-cncr2820720608>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  41. Wallace J. L. Gastric ulceration: critical events at the neutrophil--endothelium interface. Can J Physiol Pharmacol. 1993 Jan;71(1):98–102. doi: 10.1139/y93-014. [DOI] [PubMed] [Google Scholar]
  42. Yeomans N. D. Bacteria in ulcer pathogenesis. Baillieres Clin Gastroenterol. 1988 Jul;2(3):573–591. doi: 10.1016/s0950-3528(88)80006-x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES